Natalie R Saunders

发表

A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction

J. Kastrup, R. Rakhit, M. Parmar, 2018 .

A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial

J. Kastrup, R. Rakhit, M. Parmar, 2015, European heart journal.

The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease.

A. Mathur, A. Wragg, John F. Martin, 2013, Stem cells and development.

Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells

K. Subbarao, J. Crawford, E. B. Clemens, 2023, Cell Reports Medicine.

Prospective comprehensive profiling of immune responses to COVID‐19 vaccination in patients on zanubrutinib therapy

Thi H. O. Nguyen, K. Kedzierska, L. Rowntree, 2023, EJHaem.

Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations.

A. Mathur, D. Locca, S. Agrawal, 2009, Regenerative medicine.

Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial

M. Cowie, M. Parmar, F. Choudry, 2015, European heart journal.

An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE‐IHD clinical trial

M. Parmar, F. Choudry, A. Mathur, 2016, European journal of heart failure.

Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study.

R. Archbold, A. Mathur, M. Rothman, 2014, Regenerative medicine.